Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Leidos Awarded DARPA Contract for Personalized Protective Biosystem Against Chemical and Biological Threats

by Global Biodefense Staff
September 29, 2021
Leidos Awarded DARPA Contract for Personalized Protective Biosystem Against Chemical and Biological Threats

Credit: DARPA

Personalized Protective Biosystem (PPB) program aims to develop technology that reduces the need for burdensome protective equipment while increasing individual protection against CB threats.

Leidos will develop technology that reduces the need for burdensome protective equipment while increasing defense against both existing and future chemical and biological threats under a new prime contract awarded by the Defense Advanced Research Projects Agency (DARPA).

This three-phase, five-year cost-plus-fixed-fee contract has a total ceiling value of $19.3 million. DARPA announced Leidos’ selection for the PPB effort on April 19. Leidos further elaborated on the award in a Sep 29 company release.

DARPA’s Personalized Protective Biosystem (PPB) program addresses the need for lightweight and adaptive personal protection equipment for military and healthcare personnel. The recent pandemic highlighted this challenge on a global scale.

Through this award, Leidos is launching a combination of innovative, robust and flexible platforms known as Smart Protective Integrated Dynamic Ensemble for Reactive, Multifaceted Agent Neutralization (SPIDERMAN). The technology comes in the form of both lightweight protective materials and tissue-protective countermeasures. It enables Chemical-Biological threat protection without prior knowledge of the agent’s nature.

The goal is to create new and improved ways to address different, emerging and uncharacterized threats through advanced technology.

[ Read more: Personalized Protective Biosystems: DARPA Program Developing Innovative Threat Barriers ]

“Leidos has assembled a world-class team and is proud to lead the execution of this revolutionary program,” said Dr. John Dresios, Executive Biology Director and Principal Investigator for the Leidos PPB team. “SPIDERMAN has the potential to deliver transformative advancements that will provide broad and specific, as well as rapid and sustainable protection against chemical and biological threats. We’re excited to help engineer new ways to protect the military and our nation.”

The PPB program team is collaborating with government and industry stakeholders – including the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), Biomedical Advanced Research and Development Authority (BARDA), U.S. Center for Disease Control /National Personal Protective Technology Laboratory (NPPTL), and World Health Organization International (WHO) – to serve as potential transition partners.

DARPA’s PPB team and performers will be working with the U.S. Food and Drug Administration to ensure all relevant guidelines are adhered to and regulatory standards are met, with the expectation of Investigational New Drug (IND) approval by the conclusion of the program, for relevant components.

Tags: ASPRAwardsChemical WeaponsDARPAEditor PickForce ProtectionHHSIndividual ProtectionSelect Agents

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy